These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17341851)

  • 1. COX-2 inhibition and the prevention of gastric cancer.
    Lee DS; Moss SF
    Digestion; 2006; 74(3-4):184-6. PubMed ID: 17341851
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoprevention of gastric cancer: role of COX-2 inhibitors and other agents.
    Nardone G; Rocco A
    Dig Dis; 2004; 22(4):320-6. PubMed ID: 15812154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term effect of Helicobacter pylori eradication on COX-1/2, 5-LOX and leukotriene receptors in patients with a risk gastritis phenotype--a link to gastric carcinogenesis.
    Venerito M; Kuester D; Wex T; Roessner A; Malfertheiner P; Treiber G
    Cancer Lett; 2008 Nov; 270(2):218-28. PubMed ID: 18571838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental NSAID-associated gastric mucosa injuries].
    Varvanina GG; Tkachenko EV; Drozdov VN; Trubitsyna IE
    Eksp Klin Gastroenterol; 2008; (6):34-5. PubMed ID: 19334425
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point.
    Arber N
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1852-7. PubMed ID: 18708371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of topically applied non-steroidal anti-inflammatory drugs for oral cancer chemoprevention.
    Sood S; Shiff SJ; Yang CS; Chen X
    Oral Oncol; 2005 Jul; 41(6):562-7. PubMed ID: 15975519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aspirin--a suitable drug for cancer prevention?].
    Taubert D; Berkels R; Schömig E
    Dtsch Med Wochenschr; 2004 Feb; 129(9):439-42. PubMed ID: 14970916
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemoprevention of gastric cancer: has the time come?
    Correa P
    J Clin Oncol; 2003 Dec; 21(23 Suppl):270s-271s. PubMed ID: 14645407
    [No Abstract]   [Full Text] [Related]  

  • 11. New celecoxib derivatives as anti-inflammatory agents.
    Szabó G; Fischer J; Kis-Varga A; Gyires K
    J Med Chem; 2008 Jan; 51(1):142-7. PubMed ID: 18072726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
    Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
    Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection.
    Park ES; Do IG; Park CK; Kang WK; Noh JH; Sohn TS; Kim S; Kim MJ; Kim KM
    Clin Cancer Res; 2009 Jan; 15(1):291-8. PubMed ID: 19118057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pain game.
    Wadman M
    Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159
    [No Abstract]   [Full Text] [Related]  

  • 15. [Colorectal cancer chemoprevention].
    Starzyńka T; Wasilewicz MP
    Pol Merkur Lekarski; 2007 Jul; 23(133):70-3. PubMed ID: 18051834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 and tumor biology.
    Kanaoka S; Takai T; Yoshida K
    Adv Clin Chem; 2007; 43():59-78. PubMed ID: 17249380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of cyclooxygenase-2 and urokinase plasminogen activator in gastric carcinoma and the clinical significance thereof].
    Zhang FH; Zhou YN; Li GZ; Li Q; Lu B; Zhang ZY; Wu ZQ; Fan P; Hao TJ
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3279-82. PubMed ID: 19159555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAIDs and breast cancer: a possible prevention and treatment strategy.
    Agrawal A; Fentiman IS
    Int J Clin Pract; 2008 Mar; 62(3):444-9. PubMed ID: 18194278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic cyclooxygenase-2 expression and high salt enhanced susceptibility to chemical-induced gastric cancer development in mice.
    Leung WK; Wu KC; Wong CY; Cheng AS; Ching AK; Chan AW; Chong WW; Go MY; Yu J; To KF; Wang X; Chui YL; Fan DM; Sung JJ
    Carcinogenesis; 2008 Aug; 29(8):1648-54. PubMed ID: 18611916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric mucosal defense and cytoprotection: bench to bedside.
    Laine L; Takeuchi K; Tarnawski A
    Gastroenterology; 2008 Jul; 135(1):41-60. PubMed ID: 18549814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.